Given the fact that most genetic alterations of MAP3K8 in ccRCC is of no significance, further investigations will be necessary to incorporate MAP3K8 into assay design and focus on genetic fusion, rearrangement, amplification, or other genetic alterations conferring MAPK pathway dependency. Here, MAP3K8 is linked to nonpapillary renal cell carcinoma.